218 related articles for article (PubMed ID: 29545197)
1. Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.
Yu J; Zanotti S; Schilling L; Schoenherr C; Economides AN; Sanjay A; Canalis E
Am J Pathol; 2018 Jun; 188(6):1430-1446. PubMed ID: 29545197
[TBL] [Abstract][Full Text] [Related]
2. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
4. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
5. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
6. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
7. The Hajdu Cheney Mutation Is a Determinant of B-Cell Allocation of the Splenic Marginal Zone.
Yu J; Zanotti S; Walia B; Jellison E; Sanjay A; Canalis E
Am J Pathol; 2018 Jan; 188(1):149-159. PubMed ID: 29037852
[TBL] [Abstract][Full Text] [Related]
8. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
9. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
10. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
11. NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.
Canalis E; Schilling L; Yu J; Denker E
J Biol Chem; 2024 Feb; 300(2):105613. PubMed ID: 38159855
[TBL] [Abstract][Full Text] [Related]
12. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.
Zhao W; Petit E; Gafni RI; Collins MT; Robey PG; Seton M; Miller KK; Mannstadt M
Osteoporos Int; 2013 Aug; 24(8):2275-81. PubMed ID: 23389697
[TBL] [Abstract][Full Text] [Related]
13. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
14. NOTCH2 Hajdu-Cheney Mutations Escape SCF
Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
[TBL] [Abstract][Full Text] [Related]
15. Hajdu-Cheney Syndrome: A Systematic Review of the Literature.
Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Rodríguez-Blanque R; Bermejo-Fernández A; Sánchez-García JC
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32854429
[TBL] [Abstract][Full Text] [Related]
16. Hajdu-Cheney syndrome: a review.
Canalis E; Zanotti S
Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
[TBL] [Abstract][Full Text] [Related]
17. CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling.
Hampel F; Ehrenberg S; Hojer C; Draeseke A; Marschall-Schröter G; Kühn R; Mack B; Gires O; Vahl CJ; Schmidt-Supprian M; Strobl LJ; Zimber-Strobl U
Blood; 2011 Dec; 118(24):6321-31. PubMed ID: 21795747
[TBL] [Abstract][Full Text] [Related]
18. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
Isidor B; Le Merrer M; Exner GU; Pichon O; Thierry G; Guiochon-Mantel A; David A; Cormier-Daire V; Le Caignec C
Hum Mutat; 2011 Nov; 32(11):1239-42. PubMed ID: 21793104
[TBL] [Abstract][Full Text] [Related]
19. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
20. A novel NOTCH2 mutation identified in a Korean family with Hajdu-Cheney syndrome showing phenotypic diversity.
Han MS; Ko JM; Cho TJ; Park WY; Cheong HI
Ann Clin Lab Sci; 2015; 45(1):110-4. PubMed ID: 25696021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
